| Year |
Citation |
Score |
| 2023 |
Snyder KM, Dixon KJ, Davis Z, Hosking M, Hart G, Khaw M, Matson A, Bjordahl R, Hancock B, Shirinbak S, Miller JS, Valamehr B, Wu J, Walcheck B. iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting. Journal For Immunotherapy of Cancer. 11. PMID 38056893 DOI: 10.1136/jitc-2023-007280 |
0.317 |
|
| 2022 |
Cichocki F, Goodridge J, Bjordahl R, Mahmood S, Davis ZB, Gaidarova S, Abujarour R, Groff B, Witty AD, Wang H, Tuininga K, Kodal B, Felices M, Bonello GB, Huffman J, ... ... Walcheck B, et al. Dual-antigen targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia. Blood. PMID 35917442 DOI: 10.1182/blood.2021015184 |
0.31 |
|
| 2022 |
Hullsiek R, Li Y, Snyder KM, Wang S, Di D, Borgatti A, Lee C, Moore PF, Zhu C, Fattori C, Modiano JF, Wu J, Walcheck B. Examination of IgG Fc Receptor CD16A and CD64 Expression by Canine Leukocytes and Their ADCC Activity in Engineered NK Cells. Frontiers in Immunology. 13: 841859. PMID 35281028 DOI: 10.3389/fimmu.2022.841859 |
0.338 |
|
| 2020 |
Snyder KM, McAloney CA, Montel JS, Modiano JF, Walcheck B. Ectodomain shedding by ADAM17 (a disintegrin and metalloproteinase 17) in canine neutrophils. Veterinary Immunology and Immunopathology. 231: 110162. PMID 33264689 DOI: 10.1016/j.vetimm.2020.110162 |
0.377 |
|
| 2020 |
Mishra HK, Ma J, Mendez D, Hullsiek R, Pore N, Walcheck B. Blocking ADAM17 Function with a Monoclonal Antibody Improves Sepsis Survival in a Murine Model of Polymicrobial Sepsis. International Journal of Molecular Sciences. 21. PMID 32932701 DOI: 10.3390/Ijms21186688 |
0.405 |
|
| 2020 |
Goodridge JP, Reiser JW, Bjordahl R, Mandal M, Chang C, Clarck R, Mahmood S, Zhu H, Gaidarova S, Blum R, Cichocki F, Hsu H, Bonello G, Lee T, Groff B, ... ... Walcheck B, et al. Abstract 2216: Combinational strategy targeting B cell malignancy using iPSC engineered CAR-NK (FT596) and CAR-T cell (FT819) platforms with therapeutic antibody to achieve an effective deep and durable response Immunology. DOI: 10.1158/1538-7445.Am2020-2216 |
0.333 |
|
| 2019 |
Zhu H, Blum R, Bjordahl R, Gaidarova S, Rogers P, Lee TT, Abujarour R, Bonello GB, Wu J, Tsai PF, Miller JS, Walcheck B, Valamehr B, Kaufman DS. Pluripotent stem cell-derived NK cells with high-affinity non-cleavable CD16a mediate improved anti-tumor activity. Blood. PMID 31856277 DOI: 10.1182/Blood.2019000621 |
0.425 |
|
| 2019 |
Pomeroy EJ, Hunzeker JT, Kluesner MG, Lahr WS, Smeester BA, Crosby MR, Lonetree CL, Yamamoto K, Bendzick L, Miller JS, Geller MA, Walcheck B, Felices M, Webber BR, Starr TK, et al. A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31704085 DOI: 10.1016/J.Ymthe.2019.10.009 |
0.362 |
|
| 2019 |
Walcheck B, Wu J. iNK-CD64/16A cells: A promising approach for ADCC? Expert Opinion On Biological Therapy. PMID 31510805 DOI: 10.1080/14712598.2019.1667974 |
0.355 |
|
| 2019 |
Wu J, Mishra HK, Walcheck B. Role of ADAM17 as a regulatory checkpoint of CD16A in NK cells and as a potential target for cancer immunotherapy. Journal of Leukocyte Biology. PMID 30786043 DOI: 10.1002/Jlb.2Mr1218-501R |
0.405 |
|
| 2019 |
Goodridge JP, Mahmood S, Zhu H, Gaidarova S, Blum R, Bjordahl R, Cichocki F, Chu H, Bonello G, Lee T, Groff B, Meza M, Walcheck B, Malmberg K, Miller JS, et al. FT596: Translation of First-of-Kind Multi-Antigen Targeted Off-the-Shelf CAR-NK Cell with Engineered Persistence for the Treatment of B Cell Malignancies Blood. 134: 301-301. DOI: 10.1182/Blood-2019-129319 |
0.314 |
|
| 2019 |
Goodridge J, Mahmood S, Zhu H, Gaidarova S, Blum R, Bjordahl R, Cichocki F, Chu H, Bonello G, Lee T, Groff B, Malmberg K, Walcheck B, Miller J, Kaufman D, et al. Abstract 3207: Preclinical development of first-of-kind dual-targeted off-the-shelf CAR-NK cell product with engineered persistence for an effective treatment of B cell malignancies Cancer Research. 79: 3207-3207. DOI: 10.1158/1538-7445.Sabcs18-3207 |
0.402 |
|
| 2019 |
Bjordahl R, Zhu H, Rogers P, Gaidarova S, Ge MQ, Blum R, Cichocki F, Goodridge J, Chu H, Bonello G, Lee T, Groff B, Abujarour R, Walcheck B, Miller J, et al. Abstract 3191: FT516, an off-the-shelf engineered NK cell therapeutic product for universal anti-tumor targeting strategy in combination with monoclonal antibodies Cancer Research. 79: 3191-3191. DOI: 10.1158/1538-7445.Am2019-3191 |
0.425 |
|
| 2018 |
Snyder KM, Hullsiek R, Mishra HK, Mendez DC, Li Y, Rogich A, Kaufman DS, Wu J, Walcheck B. Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells. Frontiers in Immunology. 9: 2873. PMID 30574146 DOI: 10.3389/Fimmu.2018.02873 |
0.431 |
|
| 2018 |
Mishra HK, Pore N, Michelotti EF, Walcheck B. Anti-ADAM17 monoclonal antibody MEDI3622 increases IFNγ production by human NK cells in the presence of antibody-bound tumor cells. Cancer Immunology, Immunotherapy : Cii. PMID 29978334 DOI: 10.1007/S00262-018-2193-1 |
0.395 |
|
| 2018 |
Kaufman DS, Bjordahl R, Zhu H, Blum R, Bahena A, Mahmood S, Bonello G, Lee T, Walcheck B, Cichocki F, Miller JS, Valamehr B. Off-the-Shelf Natural Killer Cells with Multi-Functional Engineering Using a Novel Anti-CD19 Chimeric Antigen Receptor Combined with Stabilized CD16 and IL15 Expression to Enhance Directed Anti-Tumor Activity Blood. 132: 4541-4541. DOI: 10.1182/Blood-2018-99-113701 |
0.424 |
|
| 2018 |
Mishra HK, Jianming W, Pore N, Walcheck B. Abstract B57: Effect of ADAM17 inhibition on the release of IFN-y during natural killer cell-mediated antibody dependent cellular cytotoxicity in cancer Cancer Immunology Research. 6. DOI: 10.1158/2326-6074.Tumimm17-B57 |
0.402 |
|
| 2017 |
Mishra HK, Ma J, Walcheck B. Ectodomain Shedding by ADAM17: Its Role in Neutrophil Recruitment and the Impairment of This Process during Sepsis. Frontiers in Cellular and Infection Microbiology. 7: 138. PMID 28487846 DOI: 10.3389/Fcimb.2017.00138 |
0.451 |
|
| 2017 |
Zhu H, Bjordahl R, Gaidarova S, Rogers P, Blum R, Kaufman D, Walcheck B, Valamehr B. Genetically Engineered Pluripotent Cell-Derived Natural Killer Cell Therapy Provides Enhanced Antibody Dependent Cellular Cytotoxicity Against Hematologic Malignancies and Solid Tumors in Combination with Monoclonal Antibody Therapy Blood. 130: 4452-4452. DOI: 10.1182/Blood.V130.Suppl_1.4452.4452 |
0.429 |
|
| 2017 |
Mishra HK, Wu J, Kaufman DS, Walcheck B. Abstract 800: Enhancing tumor killing abilities of NK cells by targeting CD16 shedding, and ADAM17 Cancer Research. 77: 800-800. DOI: 10.1158/1538-7445.Am2017-800 |
0.346 |
|
| 2017 |
Bjordahl R, Cichocki F, Clarke R, Gaidarova S, Groff B, Rogers P, Moreno S, Abujarour R, Bonello G, Lee T, Lan W, Bauer M, Robbins D, Rezner B, Cooley S, ... Walcheck B, et al. Abstract 3755: Renewable and genetically engineered natural killer cells for off-the-shelf adoptive cellular immunotherapy Cancer Research. 77: 3755-3755. DOI: 10.1158/1538-7445.Am2017-3755 |
0.403 |
|
| 2016 |
Ku AW, Muhitch JB, Powers CA, Diehl MG, Kim M, Fisher DT, Sharda AP, Clements VK, O'Loughlin K, Minderman H, Messmer MN, Ma J, Skitzki JJ, Steeber DA, Walcheck B, et al. Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes. Elife. 5. PMID 27929373 DOI: 10.7554/Elife.17375 |
0.434 |
|
| 2016 |
Bohrer LR, Chaffee TS, Chuntova P, Brady NJ, Witschen PM, Kemp SE, Nelson AC, Walcheck B, Schwertfeger KL. ADAM17 in tumor associated leukocytes regulates inflammatory mediators and promotes mammary tumor formation. Genes & Cancer. 7: 240-253. PMID 27738494 DOI: 10.18632/Genesandcancer.115 |
0.344 |
|
| 2016 |
Mishra HK, Johnson TJ, Seelig DM, Walcheck B. Targeting ADAM17 in leukocytes increases neutrophil recruitment and reduces bacterial spread during polymicrobial sepsis. Journal of Leukocyte Biology. PMID 27059842 DOI: 10.1189/Jlb.3Vmab1115-496Rr |
0.442 |
|
| 2016 |
Blum R, Arumugam A, Wu J, Walcheck B, Kaufman D. Engineering Human Pluripotent Stem Cell-Derived Natural Killer Cells to Prevent CD16a Shedding for Enhanced Anti-Tumor Killing Blood. 128: 1336-1336. DOI: 10.1182/Blood.V128.22.1336.1336 |
0.418 |
|
| 2016 |
Boylan KLM, Buchanan PC, Shukla D, DeRycke M, Walcheck B, APNS. Abstract B58: Functional analysis of the cell adhesion molecule Nectin-4 in the unique tumor microenvironment of ovarian cancer. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-B58 |
0.361 |
|
| 2015 |
Jing Y, Ni Z, Wu J, Higgins L, Markowski TW, Kaufman DS, Walcheck B. Identification of an ADAM17 cleavage region in human CD16 (FcγRIII) and the engineering of a non-cleavable version of the receptor in NK cells. Plos One. 10: e0121788. PMID 25816339 DOI: 10.1371/Journal.Pone.0121788 |
0.763 |
|
| 2015 |
Mishra HK, Long C, Bahaie NS, Walcheck B. Regulation of CXCR2 expression and function by a disintegrin and metalloprotease-17 (ADAM17). Journal of Leukocyte Biology. 97: 447-54. PMID 25412626 DOI: 10.1189/Jlb.3Hi0714-340R |
0.787 |
|
| 2015 |
Becker AM, Walcheck B, Bhattacharya D. ADAM17 limits the expression of CSF1R on murine hematopoietic progenitors. Experimental Hematology. 43: 44-52.e1-3. PMID 25308957 DOI: 10.1016/J.Exphem.2014.10.001 |
0.409 |
|
| 2015 |
Boylan KLM, Buchanan PC, Meyer A, Walcheck B, Skubitz APN. Abstract POSTER-BIOL-1304: Cleavage of the cell adhesion molecule nectin-4 from the surface of ovarian cancer cells: a mechanism for cancer progression and a novel serum biomarker Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Ovcasymp14-Poster-Biol-1304 |
0.355 |
|
| 2013 |
Wiernik A, Foley B, Zhang B, Verneris MR, Warlick E, Gleason MK, Ross JA, Luo X, Weisdorf DJ, Walcheck B, Vallera DA, Miller JS. Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 3844-55. PMID 23690482 DOI: 10.1158/1078-0432.Ccr-13-0505 |
0.383 |
|
| 2013 |
Romee R, Foley B, Lenvik T, Wang Y, Zhang B, Ankarlo D, Luo X, Cooley S, Verneris M, Walcheck B, Miller J. NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17). Blood. 121: 3599-608. PMID 23487023 DOI: 10.1182/Blood-2012-04-425397 |
0.421 |
|
| 2013 |
Wang Y, Wu J, Newton R, Bahaie NS, Long C, Walcheck B. ADAM17 cleaves CD16b (FcγRIIIb) in human neutrophils. Biochimica Et Biophysica Acta. 1833: 680-5. PMID 23228566 DOI: 10.1016/J.Bbamcr.2012.11.027 |
0.786 |
|
| 2012 |
Long C, Hosseinkhani MR, Wang Y, Sriramarao P, Walcheck B. ADAM17 activation in circulating neutrophils following bacterial challenge impairs their recruitment. Journal of Leukocyte Biology. 92: 667-72. PMID 22623356 DOI: 10.1189/Jlb.0312112 |
0.783 |
|
| 2011 |
Wang Y, Robertson JD, Walcheck B. Different signaling pathways stimulate a disintegrin and metalloprotease-17 (ADAM17) in neutrophils during apoptosis and activation. The Journal of Biological Chemistry. 286: 38980-8. PMID 21949123 DOI: 10.1074/Jbc.M111.277087 |
0.401 |
|
| 2011 |
Arndt PG, Strahan B, Wang Y, Long C, Horiuchi K, Walcheck B. Leukocyte ADAM17 regulates acute pulmonary inflammation. Plos One. 6: e19938. PMID 21603616 DOI: 10.1371/Journal.Pone.0019938 |
0.77 |
|
| 2011 |
Romee R, Lenvik T, Wang Y, Walcheck B, Verneris MR, Miller JS. ADAM17, a Novel Metalloproteinase, Mediates CD16 and CD62L Shedding in Human NK Cells and Modulates IFNγ Responses Blood. 118: 2184-2184. DOI: 10.1182/Blood.V118.21.2184.2184 |
0.431 |
|
| 2010 |
Wang Y, Zhang AC, Ni Z, Herrera A, Walcheck B. ADAM17 activity and other mechanisms of soluble L-selectin production during death receptor-induced leukocyte apoptosis. Journal of Immunology (Baltimore, Md. : 1950). 184: 4447-54. PMID 20220092 DOI: 10.4049/Jimmunol.0902925 |
0.778 |
|
| 2010 |
Long C, Wang Y, Herrera AH, Horiuchi K, Walcheck B. In vivo role of leukocyte ADAM17 in the inflammatory and host responses during E. coli-mediated peritonitis. Journal of Leukocyte Biology. 87: 1097-101. PMID 20154226 DOI: 10.1189/Jlb.1109763 |
0.778 |
|
| 2009 |
Ni Z, Walcheck B. Cutaneous lymphocyte-associated antigen (CLA) T cells up-regulate P-selectin ligand expression upon their activation Clinical Immunology. 133: 257-264. PMID 19665434 DOI: 10.1016/J.Clim.2009.07.010 |
0.764 |
|
| 2009 |
Hill CAS, Farooqui M, Mitcheltree G, Gulbahce HE, Jessurun J, Cao Q, Walcheck B. The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 β-1,6-N-acetylglusaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas Bmc Cancer. 9: 79-79. PMID 19267921 DOI: 10.1186/1471-2407-9-79 |
0.339 |
|
| 2009 |
Wang Y, Herrera AH, Li Y, Belani KK, Walcheck B. Regulation of mature ADAM17 by redox agents for L-selectin shedding. Journal of Immunology. 182: 2449-2457. PMID 19201900 DOI: 10.4049/Jimmunol.0802770 |
0.478 |
|
| 2008 |
Schaff U, Mattila PE, Simon SI, Walcheck B. Neutrophil adhesion to E-selectin under shear promotes the redistribution and co-clustering of ADAM17 and its proteolytic substrate L-selectin. Journal of Leukocyte Biology. 83: 99-105. PMID 17928459 DOI: 10.1189/Jlb.0507304 |
0.793 |
|
| 2007 |
Jutila MA, Walcheck B, Bargatze R, Palecanda A. Measurement of neutrophil adhesion under conditions mimicking blood flow. Methods in Molecular Biology (Clifton, N.J.). 412: 239-56. PMID 18453116 DOI: 10.1007/978-1-59745-467-4_16 |
0.34 |
|
| 2007 |
Duchesneau P, Gallagher E, Walcheck B, Waddell TK. Up-regulation of leukocyte CXCR4 expression by sulfatide: an L-selectin-dependent pathway on CD4+ T cells. European Journal of Immunology. 37: 2949-60. PMID 17853408 DOI: 10.1002/Eji.200737118 |
0.512 |
|
| 2007 |
Dileepan T, Kannan MS, Walcheck B, Maheswaran SK. Integrin-EGF-3 domain of bovine CD18 is critical for Mannheimia haemolytica leukotoxin species-specific susceptibility. Fems Microbiology Letters. 274: 67-72. PMID 17590223 DOI: 10.1111/J.1574-6968.2007.00818.X |
0.324 |
|
| 2007 |
Bell JH, Herrera AH, Li Y, Walcheck B. Role of ADAM17 in the ectodomain shedding of TNF-alpha and its receptors by neutrophils and macrophages. Journal of Leukocyte Biology. 82: 173-6. PMID 17510296 DOI: 10.1189/Jlb.0307193 |
0.34 |
|
| 2007 |
Ni Z, Walcheck B. Varied levels of reactivity by different E-selectin/Fc constructs with cutaneous lymphocyte-associated antigen (CLA)+ CD4+ T cells Immunology Letters. 108: 179-182. PMID 17222460 DOI: 10.1016/J.Imlet.2006.12.002 |
0.762 |
|
| 2006 |
Ni Z, Campbell JJ, Niehans G, Walcheck B. The monoclonal antibody CHO-131 identifies a subset of cutaneous lymphocyte-associated antigen T cells enriched in P-selectin-binding cells. Journal of Immunology (Baltimore, Md. : 1950). 177: 4742-8. PMID 16982914 DOI: 10.4049/Jimmunol.177.7.4742 |
0.749 |
|
| 2006 |
Li Y, Brazzell J, Herrera A, Walcheck B. ADAM17 deficiency by mature neutrophils has differential effects on L-selectin shedding Blood. 108: 2275-2279. PMID 16735599 DOI: 10.1182/Blood-2006-02-005827 |
0.468 |
|
| 2006 |
Descheny L, Gainers ME, Walcheck B, Dimitroff CJ. Ameliorating Skin-Homing Receptors on Malignant T Cells with a Fluorosugar Analog of N-acetylglucosamine: P-Selectin Ligand Is a More Sensitive Target than E-Selectin Ligand Journal of Investigative Dermatology. 126: 2065-2073. PMID 16691194 DOI: 10.1038/Sj.Jid.5700364 |
0.409 |
|
| 2006 |
Walcheck B, Herrera AH, St Hill C, Mattila PE, Whitney AR, Deleo FR. ADAM17 activity during human neutrophil activation and apoptosis. European Journal of Immunology. 36: 968-76. PMID 16541467 DOI: 10.1002/Eji.200535257 |
0.79 |
|
| 2005 |
Dileepan T, Kannan MS, Walcheck B, Thumbikat P, Maheswaran SK. Mapping of the binding site for Mannheimia haemolytica leukotoxin within bovine CD18. Infection and Immunity. 73: 5233-7. PMID 16041046 DOI: 10.1128/Iai.73.8.5233-5237.2005 |
0.346 |
|
| 2005 |
Dileepan T, Thumbikat P, Walcheck B, Kannan MS, Maheswaran SK. Recombinant expression of bovine LFA-1 and characterization of its role as a receptor for Mannheimia haemolytica leukotoxin. Microbial Pathogenesis. 38: 249-57. PMID 15925274 DOI: 10.1016/J.Micpath.2005.02.005 |
0.452 |
|
| 2005 |
Zou X, Shinde Patil VR, Dagia NM, Smith LA, Wargo MJ, Interliggi KA, Lloyd CM, Tees DF, Walcheck B, Lawrence MB, Goetz DJ. PSGL-1 derived from human neutrophils is a high-efficiency ligand for endothelium-expressed E-selectin under flow. American Journal of Physiology. Cell Physiology. 289: C415-24. PMID 15814589 DOI: 10.1152/Ajpcell.00289.2004 |
0.382 |
|
| 2005 |
Mattila PE, Green CE, Schaff U, Simon SI, Walcheck B. Cytoskeletal interactions regulate inducible L-selectin clustering. American Journal of Physiology. Cell Physiology. 289: C323-32. PMID 15788481 DOI: 10.1152/Ajpcell.00603.2004 |
0.761 |
|
| 2005 |
Moritz A, Walcheck BK, Weiss DJ. Evaluation of flow cytometric and automated methods for detection of activated platelets in dogs with inflammatory disease. American Journal of Veterinary Research. 66: 325-9. PMID 15757135 DOI: 10.2460/Ajvr.2005.66.325 |
0.307 |
|
| 2005 |
Hill CAS, Bullard KM, Walcheck B. Expression of the high-affinity selectin glycan ligand C2-O-sLeX by colon carcinoma cells. Cancer Letters. 217: 105-113. PMID 15596301 DOI: 10.1016/J.Canlet.2004.06.038 |
0.388 |
|
| 2004 |
Weiss DJ, Welle M, Mortiz A, Walcheck B. Evaluation of leukocyte cell surface markers in dogs with septic and nonseptic inflammatory diseases. American Journal of Veterinary Research. 65: 59-63. PMID 14719703 DOI: 10.2460/Ajvr.2004.65.59 |
0.396 |
|
| 2003 |
Walcheck B, Alexander SR, St. Hill CA, Matala E. ADAM-17-independent shedding of L-selectin Journal of Leukocyte Biology. 74: 389-394. PMID 12949242 DOI: 10.1189/Jlb.0403141 |
0.424 |
|
| 2003 |
Moritz A, Walcheck BK, Deye J, Weiss DJ. Effects of short-term racing activity on platelet and neutrophil activation in dogs. American Journal of Veterinary Research. 64: 855-9. PMID 12856769 DOI: 10.2460/Ajvr.2003.64.855 |
0.397 |
|
| 2003 |
St. Hill CA, Alexander SR, Walcheck B. Indirect capture augments leukocyte accumulation on P-selectin in flowing whole blood Journal of Leukocyte Biology. 73: 464-471. PMID 12660221 DOI: 10.1189/Jlb.1002491 |
0.447 |
|
| 2002 |
Walcheck B, Leppanen A, Cummings RD, Knibbs RN, Stoolman LM, Alexander SR, Mattila PE, McEver RP. The monoclonal antibody CHO-131 binds to a core 2 O-glycan terminated with sialyl-Lewis x, which is a functional glycan ligand for P-selectin. Blood. 99: 4063-9. PMID 12010808 DOI: 10.1182/Blood-2001-12-0265 |
0.769 |
|
| 2001 |
Matala E, Alexander SR, Kishimoto TK, Walcheck B. The cytoplasmic domain of L-selectin participates in regulating L-selectin endoproteolysis Journal of Immunology. 167: 1617-1623. PMID 11466384 DOI: 10.4049/Jimmunol.167.3.1617 |
0.415 |
|
| 2001 |
Zhang X, Brewer L, Walcheck B, Johnson A, Pease LR, Njenga MK. Theiler's virus-infected L-selectin-deficient mice have decreased infiltration of CD8(+) T lymphocytes in central nervous system but clear the virus. Journal of Neuroimmunology. 116: 178-87. PMID 11438172 DOI: 10.1016/S0165-5728(01)00296-X |
0.373 |
|
| 2001 |
Kulkarni-Narla A, Walcheck B, Brown DR. Opioid receptors on bone marrow neutrophils modulate chemotaxis and CD11b/CD18 expression. European Journal of Pharmacology. 414: 289-94. PMID 11239930 DOI: 10.1016/S0014-2999(01)00727-0 |
0.319 |
|
| 2000 |
McClenahan DJ, Evanson OA, Walcheck BK, Weiss DJ. Association among filamentous actin content, CD11b expression, and membrane deformability in stimulated and unstimulated bovine neutrophils. American Journal of Veterinary Research. 61: 380-6. PMID 10772101 DOI: 10.2460/Ajvr.2000.61.380 |
0.394 |
|
| 2000 |
Alexander SR, Kishimoto TK, Walcheck B. Effects of selective protein kinase C inhibitors on the proteolytic down-regulation of L-selectin from chemoattractant-activated neutrophils Journal of Leukocyte Biology. 67: 415-422. PMID 10733103 DOI: 10.1002/Jlb.67.3.415 |
0.366 |
|
| 2000 |
Jeyaseelan S, Hsuan SL, Kannan MS, Walcheck B, Wang JF, Kehrli ME, Lally ET, Sieck GC, Maheswaran SK. Lymphocyte function-associated antigen 1 is a receptor for Pasteurella haemolytica leukotoxin in bovine leukocytes. Infection and Immunity. 68: 72-9. PMID 10603370 DOI: 10.1128/Iai.68.1.72-79.2000 |
0.434 |
|
| 1998 |
Wilson E, Walcheck B, Davis WC, Jutila MA. Preferential tissue localization of bovine gamma delta T cell subsets defined by anti-T cell receptor for antigen antibodies. Immunology Letters. 64: 39-44. PMID 9865600 DOI: 10.1016/S0165-2478(98)00077-7 |
0.391 |
|
| 1998 |
Kahn J, Walcheck B, Migaki GI, Jutila MA, Kishimoto TK. Calmodulin regulates L-selectin adhesion molecule expression and function through a protease-dependent mechanism. Cell. 92: 809-18. PMID 9529256 DOI: 10.1016/S0092-8674(00)81408-7 |
0.44 |
|
| 1997 |
Abrahamsen MS, Lancto CA, Walcheck B, Layton W, Jutila MA. Localization of alpha/beta and gamma/delta T lymphocytes in Cryptosporidium parvum-infected tissues in naive and immune calves. Infection and Immunity. 65: 2428-33. PMID 9169784 DOI: 10.1128/Iai.65.6.2428-2433.1997 |
0.368 |
|
| 1996 |
Walcheck B, Moore KL, McEver RP, Kishimoto TK. Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1: A mechanism that amplifies initial leukocyte accumulation on P-selectin in vitro Journal of Clinical Investigation. 98: 1081-1087. PMID 8787668 DOI: 10.1172/Jci118888 |
0.467 |
|
| 1996 |
Feehan C, Darlak K, Kahn J, Walcheck B, Spatola AF, Kishimoto TK. Shedding of the lymphocyte L-selectin adhesion molecule is inhibited by a hydroxamic acid-based protease inhibitor: Identification with an L-selectin-alkaline phosphatase reporter Journal of Biological Chemistry. 271: 7019-7024. PMID 8636132 DOI: 10.1074/Jbc.271.12.7019 |
0.415 |
|
| 1996 |
Walcheck B, Kahn J, Fisher JM, Wang BB, Fisk RS, Payan DG, Feehan C, Betageri R, Darlak K, Spatola AF, Kishimoto TK. Neutrophil rolling altered by inhibition of L-selectin shedding in vitro. Nature. 380: 720-3. PMID 8614468 DOI: 10.1038/380720A0 |
0.442 |
|
| 1994 |
Walcheck B, Jutila MA. Bovine gamma delta T cells express high levels of functional peripheral lymph node homing receptor (L-selectin). International Immunology. 6: 81-91. PMID 7511930 DOI: 10.1093/Intimm/6.1.81 |
0.452 |
|
| 1993 |
Walcheck B, Watts G, Jutila MA. Bovine gamma/delta T cells bind E-selectin via a novel glycoprotein receptor: first characterization of a lymphocyte/E-selectin interaction in an animal model. The Journal of Experimental Medicine. 178: 853-63. PMID 7688790 DOI: 10.1084/Jem.178.3.853 |
0.444 |
|
| 1992 |
Jutila MA, Watts G, Walcheck B, Kansas GS. Characterization of a functionally important and evolutionarily well-conserved epitope mapped to the short consensus repeats of E-selectin and L-selectin. The Journal of Experimental Medicine. 175: 1565-73. PMID 1375266 DOI: 10.1084/Jem.175.6.1565 |
0.465 |
|
| 1992 |
Palecanda A, Walcheck B, Bishop DK, Jutila MA. Rapid activation-independent shedding of leukocyte L-selectin induced by cross-linking of the surface antigen. European Journal of Immunology. 22: 1279-86. PMID 1374339 DOI: 10.1002/Eji.1830220524 |
0.466 |
|
| 1992 |
Walcheck B, White M, Kurk S, Kishimoto TK, Jutila MA. Characterization of the bovine peripheral lymph node homing receptor: a lectin cell adhesion molecule (LECAM). European Journal of Immunology. 22: 469-76. PMID 1371468 DOI: 10.1002/Eji.1830220227 |
0.381 |
|
| Show low-probability matches. |